Press Releases

Thursday, September 2nd, 2010

Cardiome Achieves $30 Million Milestone


Wednesday, September 1st, 2010

BRINAVESS(tm) (vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation


Wednesday, August 11th, 2010

Cardiome Reports Second Quarter Results and Updates Guidance


Tuesday, August 10th, 2010

Cardiome to Release Second Quarter Results


Friday, June 25th, 2010

Investigational BRINAVESS™ (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation


Tuesday, June 22nd, 2010

Cardiome to Present at Wells Fargo Securities 2010 Healthcare Conference


Friday, May 14th, 2010

Merck and Cardiome Announce Phase III Study Results Comparing Investigational Compound BRINAVESSTM (Vernakalant) Intravenous to Amiodarone Injection in Conversion of Atrial Fibrillation to Normal Sinus Rhythm


Tuesday, May 11th, 2010

Cardiome Reports First Quarter Results


Friday, March 19th, 2010

Cardiome to Present at Barclays Capital 2010 Global Healthcare Conference


Tuesday, March 9th, 2010

Cardiome Reports 2009 Results